GLP-1 weight loss, side effects linked to genetic variations - Reuters
GLP-1 weight loss, side effects linked to genetic variations Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
No locations linked to this story
All Coverage
<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxNTWJ0dEt6SWxYY1gxLWRjRmpuZkp5bUV3SDRjOV9tVUNGanhfTjZtT1ZXZjNkcmFNWjdZNlFHYUJfa01IMWVnR2RTWC1rQXNJSE04V21vR3BUXzJ6R0xUWmVvb2FOMlB2ZG1ZNW01NEU1RkhFZFI4akI1MWl5NGtmaVhPLXRRcmxNd3RBQzcxS0xmUFc5Vm92NUJiR2lLRFJ1QmE1VjJvdEhqYVA1U2E2Qkh4VUZRUkpaMWNiLUFzZmtHS0N0dTNiVmRpNDM2NFU?oc=5" target="_blank">GLP-1 weight loss, side effects linked to genetic variations</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Eli Lilly launches oral weight-loss pill Foundayo in UK - Reuters
Eli Lilly launches oral weight-loss pill Foundayo in UK Reuters
August 23, 2026 at 11:07 PMMore US employers to drop weight-loss drugs in 2027, as healthcare costs increase - Reuters
More US employers to drop weight-loss drugs in 2027, as healthcare costs increase Reuters
August 25, 2026 at 03:46 PMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AMRevolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
August 26, 2026 at 06:18 PMUS FDA approves Lilly's Mounjaro to reduce cardiovascular risk - Reuters
US FDA approves Lilly's Mounjaro to reduce cardiovascular risk Reuters
August 28, 2026 at 06:38 PMChina's drug regulator accepts Novo Nordisk's application for oral Wegovy - Reuters
China's drug regulator accepts Novo Nordisk's application for oral Wegovy Reuters
August 27, 2026 at 03:47 AM